Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,703.0 02/08/16
52 week low1,575.0 04/11/16
52 week change 16.0 (0.83%)
4 week volume11,550,605 27/12/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hikma unit gets FDA approval for narcolepsy drug

Hikma Pharmaceuticals' wholly-owned US subsidiary, Roxane Laboratories, has received an approval for its generic equiv...

Hikma receives approval for Sodium Oxybate

RNS Number: 4587U Hikma Pharmaceuticals Plc 18 January 2017 Hikma receives approval for Sodium Oxybate Oral Solution London, 18 January 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces that its whol...

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cu...

The market's on a last minute bargain hunt

While most in the Square Mile were still on holiday, the FTSE 100 closed at at all-time high. Now the index is taking a breat...

Director/PDMR Shareholding

RNS Number: 3967S Hikma Pharmaceuticals Plc 20 December 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the transfer of Ordinary Shares in Darhold Limited (which owns 25.00% of the Ordi...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 140,730 shares in the company on the 19th December 2016 at a price of 1827.00p. The Dir...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 140,730 shares in the company on the 19th December 2016 at a price of 1827.00p. The Dir...

Director Deals - Hikma Pharmaceuticals PLC (HIK)

Said Darwazah, Chairman, bought 140,730 shares in the company on the 19th December 2016 at a price of 1827.00p. The Dir...

Latest discussion posts More

  • Why no RNS?

    is this old news rehashed or fresh news? http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=198101#.WGy-ebGZOt9 FP
    4-Jan-2017
    Fred Prior
  • Re: Oddly enough

    Welcome back Fred. Timescales??? =================== Good evening Openwoe, I would not like to hazard a guess but this has got buy out written all over it and Barclays ...
    3-Jan-2017
    Fred Prior
  • Re: Oddly enough

    Welcome back Fred. Timescales???
    3-Jan-2017
    Openwoe

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.29%
GLAXOSMITHKLINE27%
RDS 'B'26%
VODAFONE GRP.24%
BP20%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK